Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

molecular modeling and TD risk of newer atypicals

Posted by zeugma on March 14, 2003, at 20:42:50

In reply to Re: Zyprexa TD: Real Concern?, posted by xjs7 on March 13, 2003, at 2:09:07

Here's a study that claims to identify the relative risk of EPS with particular AP's including atypicals http://www.hplc1.com/lien/neurol.html

This study may not be the most recent, but it seems interesting. According to the authors, Abilify may be the only AP besides clozapine that does not carry a risk of TD.


Share
Tweet  

Thread

 

Post a new follow-up

Your message only Include above post


Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:zeugma thread:208427
URL: http://www.dr-bob.org/babble/20030314/msgs/209194.html